View Cart  

CDER Proposes Supersizing Office of Generic Drugs, Mulls New Pharma Quality Office

A A
CDER is looking to elevate the Office of Generic Drugs (OGD) into a “super” office, a move necessitated by the recent passage of the Generic Drug User Fee Amendments (GDUFA) and a heightened public focus on generic medicines, Center Director Janet Woodcock said Friday.

To View This Article:

Login

Subscribe To Drug Industry Daily